Consult the trial pharmacist or sponsor representative
Switching medications If semaglutide side effects remain unmanageable despite dose adjustments, switching to an alternative GLP-1 receptor agonist or to tirzepatide may be appropriate
This creates a persistent "fiber gap" and an opportunity for brands to formulate products that will help consumers close it
June 1, 2026: Over 100 Lawsuits in the GLP-1 NAION MDL, Ozempic Patient Sues After Becoming Blind from NAION The GLP-1 NAION multidistrict litigation now has 110 lawsuits in it, as of June 1, 2026
This raises safety concerns for many experts, including the FDA, which explicitly warned against compounded forms of semaglutide
Advertisement There is a lot we just dont know, which is why we wanted to look at our experience here with our Cleveland Clinic patients and see whether taking GLP-1 drugs before pregnancy was causing harm or if it was beneficial and helping patients have healthier pregnancies, Dr